Mod­er­na de­creas­es mR­NA pro­duc­tion with Lon­za in Switzer­land, brings some man­u­fac­tur­ing in-house

Mod­er­na is now de­creas­ing pro­duc­tion of mR­NA sub­stance at a Lon­za plant in Switzer­land as the mar­ket for Covid-19 vac­cines wanes and the com­pa­ny’s am­bi­tious …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER